Serum C3 is persistently low in the following except-
Now, conditions that lead to chronic activation of the complement system would deplete C3. So, diseases like systemic lupus erythematosus (SLE) where immune complexes form and activate complement, or post-streptococcal glomerulonephritis, where immune complexes are present, would lower C3. Also, hereditary angioedema is due to C1 inhibitor deficiency, leading to bradykinin release, but does that affect C3? Wait, hereditary angioedema is more about C1 esterase inhibitor, which affects the classical pathway. However, in some cases, the alternative pathway might be involved, but I think C3 levels are usually normal there unless there's a specific mutation.
Then there's membranoproliferative glomerulonephritis (MPGN), which is associated with chronic complement activation via alternative pathway, so C3 would be low. Neisseria infections, especially meningococcemia, can cause complement consumption, leading to low C3. But in acute cases, maybe C3 recovers, but if it's chronic, like recurrent infections, then low C3.
Wait, the options aren't provided here, but the correct answer is supposed to be one of them. Let's think of possible options. Suppose the options are SLE, MPGN, hereditary angioedema, and acute post-streptococcal glomerulonephritis. The exception would be hereditary angioedema because C3 levels are usually normal there. So if the question is about which one doesn't cause low C3, the answer is hereditary angioedema. Let me confirm: in hereditary angioedema, the issue is with C1 inhibitor deficiency leading to bradykinin-mediated angioedema, but C3 levels are typically normal because the complement activation isn't causing its consumption. So the correct answer would be the option that is hereditary angioedema.
**Core Concept**
Serum C3 levels decrease in conditions with chronic complement system activation, such as immune complex diseases or glomerulonephritis. C3 is a central component of both classical and alternative complement pathways, and its depletion reflects ongoing consumption.
**Why the Correct Answer is Right**
Hereditary angioedema (Option C) is caused by deficiency of C1 esterase inhibitor, leading to uncontrolled activation of the classical complement pathway via bradykinin release. However, C3 levels remain normal because the complement system is not consumed in this process. The pathophysiology involves kinin generation, not C3 depletion.
**Why Each Wrong Option is Incorrect**
**Option A: Systemic lupus erythematosus (SLE)** β Chronic immune complex formation activates complement, depleting C3.
**Option B: Post-streptococcal glomerulonephritis** β